Mgo One Seven LLC Pfizer Inc Transaction History

Mgo One Seven LLC

$4.05 Billion
Q3 2025

A detailed history of Mgo One Seven LLC transactions in Pfizer Inc stock. As of the latest transaction made, Mgo One Seven LLC holds 107,131 shares of PFE stock, worth $2.64 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

107,131

Previous 84,163 27.29%

Holding current value

$2.64 Million

Previous $2.04 Million 33.77%

% of portfolio

0.07%

Previous 0.07%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	BUY	$23.29 - $25.88 $534,924 - $594,411	22,968 Added 27.29%	107,131 $2.73 Million
Q2 2025 Jul 25, 2025	SELL	$21.59 - $24.84 $735,398 - $846,100	-34,062 Reduced 28.81%	84,163 $2.04 Million
Q1 2025 May 08, 2025	BUY	$25.01 - $27.13 $149,734 - $162,427	5,987 Added 5.33%	118,225 $3 Million
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $50,840 - $61,889	2,050 Added 1.86%	112,238 $2.98 Million
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $79,415 - $89,995	-2,867 Reduced 2.54%	110,188 $3.19 Million
Q2 2024 Aug 07, 2024	SELL	$25.26 - $29.6 $58,502 - $68,553	-2,316 Reduced 2.01%	113,055 $3.16 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $138,356 - $158,877	-5,344 Reduced 4.43%	115,371 $3.2 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $948,937 - $1.23 Million	36,316 Added 43.03%	120,715 $3.48 Million
Q3 2023 Nov 03, 2023	BUY	$32.09 - $37.51 $171,841 - $200,866	5,355 Added 6.77%	84,399 $2.8 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $513,770 - $594,420	-14,224 Reduced 15.25%	79,044 $2.9 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $261,510 - $340,447	6,639 Added 7.66%	93,268 $3.81 Million
Q4 2022 Jan 25, 2023	BUY	$41.75 - $54.5 $114,019 - $148,839	2,731 Added 3.26%	86,629 $0
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $795,206 - $970,748	18,172 Added 27.65%	83,898 $6.14 Million
Q2 2022 Aug 10, 2022	SELL	$46.53 - $55.17 $104,599 - $124,022	-2,248 Reduced 3.31%	65,726 $3.45 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $171,333 - $212,304	3,745 Added 5.83%	67,974 $3.52 Million
Q4 2021 Feb 09, 2022	BUY	$41.32 - $61.25 $361,508 - $535,876	8,749 Added 15.77%	64,229 $3.79 Million
Q3 2021 Nov 09, 2021	BUY	$39.25 - $50.42 $15,346 - $19,714	391 Added 0.71%	55,480 $2.43 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $68,193 - $77,251	1,899 Added 3.57%	55,089 $2.16 Million
Q1 2021 Apr 29, 2021	BUY	$33.49 - $37.77 $64,233 - $72,442	1,918 Added 3.74%	53,190 $1.93 Million
Q4 2020 Jan 22, 2021	BUY	$33.47 - $42.56 $72,763 - $92,525	2,174 Added 4.43%	51,272 $1.89 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $214,376 - $251,512	-6,752 Reduced 12.09%	49,098 $1.8 Million
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $162,226 - $196,804	5,386 Added 10.67%	55,850 $1.83 Million
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $23,083 - $32,981	854 Added 1.72%	50,464 $1.65 Million
Q4 2019 Jan 16, 2020	SELL	$32.92 - $37.36 $37,726 - $42,814	-1,146 Reduced 2.26%	49,610 $1.94 Million
Q3 2019 Oct 10, 2019	BUY	$32.49 - $42.13 $48,670 - $63,110	1,498 Added 3.04%	50,756 $1.82 Million
Q2 2019 Jul 16, 2019	BUY	$36.98 - $41.52 $10,317 - $11,584	279 Added 0.57%	49,258 $2.13 Million
Q1 2019 Apr 09, 2019	BUY	$37.5 - $41.2 $556,537 - $611,449	14,841 Added 43.47%	48,979 $2.08 Million
Q4 2018 Jan 24, 2019	SELL	$38.47 - $43.86 $90,596 - $103,290	-2,355 Reduced 6.45%	34,138 $1.49 Million
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $2,550 - $3,093	-74 Reduced 0.2%	36,493 $1.61 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $14,231 - $16,510	446 Added 1.23%	36,567 $1.3 Million
Q4 2017 Feb 16, 2018	BUY	$33.26 - $35.29 $1.2 Million - $1.27 Million	36,121	36,121 $1.31 Million

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account